Recurrent C. difficile Infection: Bacterial Engraftment after Intestinal Microbial Transplant
Completed Trials
- In this trial, researchers monitored stool samples of patients successfully treated with Intestinal Microbiota Transplant capsules for recurrent C. difficile infections over a period of a year. All patients recovered clinically and none had exposure to antibiotics after transplant during the trial period.
- The majority of patients' microbiota resembled that of the donor throughout the entire period. However, in a quarter of patients the microbiota became entirely different from the donor at one year. In a minority of patients we did not see much in the way of donor microbiota at all.
- Read the full cited research publication here.
Achieving Cures Together is tax exempt pursuant to IRC Section 501(c)(3). Contributions are deductible to the extent allowed by law.
